Sublingual Ketorolac Compared to Intranasal Dexmedetomidine for Postoperative Analgesia in Pediatric Patients Undergoing Bilateral Myringotomy

• Status: Withdrawn
• Trial end date: 2019-05-15
• Target enrollment: 0
• Participant gender: All

Summary

The investigators aim to compare intranasal dexmedetomidine in a dose of 1ug.kg-1 with sublingual ketorolac in a dose of 1mg.kg-1 on postoperative behaviour in those children undergoing BMT during their PACU stay

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mansoura University
• Treatments: Dexmedetomidine; Ketorolac; Ketorolac Tromethamine

Criteria

Inclusion Criteria:

• ASA physical status I- II.

Exclusion Criteria:

• History of ketamine

• History of NSAID

• History of allergies

• Any bleeding disorders

• History of GIT bleeding

• Those who will undergo other procedures in addition to bilateral myringotomy